Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data
- PMID: 24625768
- PMCID: PMC4337841
Construction of a comorbidity index for prostate cancer patients linking state cancer registry with inpatient and outpatient data
Abstract
Introduction: Identifying clinically relevant comorbid conditions might lead to effective control of prostate cancer- specific risk factors and provide opportunities to improve patient care and outcomes. There are challenges in assessing comorbidity using linked databases such as statewide hospital administrative data and state cancer registry. The objective was to compile a comprehensive list of clinically relevant comorbid conditions for patients with prostate cancer using registry and statewide diagnosis databases.
Methods: Florida Cancer Data System cases were linked with the inpatient/ outpatient diagnosis information. The Elixhauser Comorbidity Index was used as a reference. Conditions not captured by Elixhauser were identified, and grouped into clinically meaningful categories. Descriptive analysis was performed on comorbidity conditions and major study population variables. Associations of comorbidity with selected demographic and disease characteristics were examined.
Results: Twenty-nine Elixhauser and 16 additional categories were examined within the 1 record per patient data set. Statistically significant association was found between comorbidity with race, stage, and age. Blacks had a higher mean number of conditions compared to whites. A higher proportion of blacks had at least 1 comorbid condition compared to whites. Additional conditions identified by this research capture more comorbidities for white men. Distinct trends towards larger number of comorbidities with older age at diagnosis and advanced disease stage were observed.
Conclusions: The Elixhauser Comorbidity Index captured the majority of comorbidities in the study population while the additional conditions identified by this research add more information. This study offers important insights into the challenges and process to identify relevant comorbidities for prostate cancer patients.
Similar articles
-
Impact of Comorbidities on Prostate Cancer Stage at Diagnosis in Florida.Am J Mens Health. 2016 Jul;10(4):285-95. doi: 10.1177/1557988314564593. Epub 2014 Dec 26. Am J Mens Health. 2016. PMID: 25542838 Free PMC article.
-
The development and validation of a comorbidity index for prostate cancer among Black men.J Clin Epidemiol. 2003 Nov;56(11):1064-75. doi: 10.1016/s0895-4356(03)00213-0. J Clin Epidemiol. 2003. PMID: 14614997
-
Vasectomy and prostate cancer in US blacks and whites.Am J Epidemiol. 1993 Feb 1;137(3):263-9. doi: 10.1093/oxfordjournals.aje.a116673. Am J Epidemiol. 1993. PMID: 8452134
-
Prostate cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology.J S C Med Assoc. 2006 Aug;102(7):241-9. J S C Med Assoc. 2006. PMID: 17319238 Review.
-
Comorbidity data collection across different spine registries: an evidence map.Eur Spine J. 2023 Mar;32(3):753-777. doi: 10.1007/s00586-023-07529-3. Epub 2023 Jan 19. Eur Spine J. 2023. PMID: 36658363 Review.
Cited by
-
Prostate cancer across four countries in the Middle East: a multi-centre, observational, retrospective and prognostic study.Ecancermedicalscience. 2024 Apr 16;18:1695. doi: 10.3332/ecancer.2024.1695. eCollection 2024. Ecancermedicalscience. 2024. PMID: 38774566 Free PMC article.
-
Comorbidity burden and health-related quality of life in men with advanced prostate cancer.Support Care Cancer. 2023 Jul 28;31(8):496. doi: 10.1007/s00520-023-07962-6. Support Care Cancer. 2023. PMID: 37501020 Free PMC article.
-
Comorbidity burden and health-related quality of life in men with advanced prostate cancer.Res Sq [Preprint]. 2023 Feb 16:rs.3.rs-2572781. doi: 10.21203/rs.3.rs-2572781/v1. Res Sq. 2023. Update in: Support Care Cancer. 2023 Jul 28;31(8):496. doi: 10.1007/s00520-023-07962-6. PMID: 36824747 Free PMC article. Updated. Preprint.
-
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status.Cancers (Basel). 2022 Apr 14;14(8):1981. doi: 10.3390/cancers14081981. Cancers (Basel). 2022. PMID: 35454886 Free PMC article.
-
GEOGRAPHICALLY-WEIGHTED REGRESSION ANALYSIS OF PERCENTAGE OF LATE-STAGE PROSTATE CANCER DIAGNOSIS IN FLORIDA.Appl Geogr. 2015 Aug 1;62:191-200. doi: 10.1016/j.apgeog.2015.04.018. Appl Geogr. 2015. PMID: 26257450 Free PMC article.
References
-
- Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–468. - PubMed
-
- Iezzoni L, Foley S, Daley J, Hughes J, Fisher E, Heeren T. Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA. 1992;267(16):2197. - PubMed
-
- Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care. 1992 - PubMed
-
- Federal Interagency Forum on Aging-Related Statistics. Older Americans 2008: Key indicators of well-being. US Independent Agencies and Commissions; 2008.
-
- Ogle KS, Swanson GM, Woods N, Azzouz F. Cancer and comorbidity. Cancer. 2000;88(3):653–663. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical